Of course, individual experiences during Semaglutide GLP-1 treatment vary, so its important to remember that everyones body responds differently
The absence of such evidence means that any potential additive or synergistic effects remain theoretical and clinical benefit is unproven
Safety analyses indicated a higher incidence of adverse events in patients without T2DM, but no increased risk of serious or hypoglycemic events was identified across interventions
Lori Suet Hang 1 , Richard Sawatzky 2 , Joanne Greenhalgh 3 , Kara Schick-Makaroff 4 1 Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada, 2 School of Nursing, Trinity Western University, Vancouver, British Columbia, Canada, 3 School of Sociology and Social Policy, University of Leeds, Leeds, UK, 4 Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :VP17 Aims People receiving dialysis commonly experience anxiety symptoms and low quality of life, yet the problem remains under-addressed
Beginning your treatment is as easy as 1-2-3
It can also lead to symptoms such as nausea, bloating, and a prolonged sensation of fullness, particularly during the dose-escalation phase